| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
19,790,381 | 21,014,999 | 16,657,343 | 18,276,547 | 17,749,982 |
| Cost of Revenue
|
-17,344,269 | -18,528,908 | -14,365,429 | -15,595,691 | -14,809,815 |
|
Gross Profit
|
2,446,112 | 2,486,091 | 2,291,914 | 2,680,856 | 2,940,167 |
| Selling, General and Administrative Expenses
|
-1,374,596 | -1,386,210 | -1,294,748 | -1,386,767 | -1,473,334 |
|
Research and Development Expenses
|
-563,470 | -563,470 | -653,335 | -- | -- |
| Depreciation, Amortization and Depletion
|
-93,722 | -93,722 | -78,650 | -- | -- |
| Provision Expense/Write-Back
|
-46,640 | -46,640 | -209,987 | -- | -- |
| Other Income/Expense, Operating
|
55,430 | 71,937 | 56,235 | 96,651 | 103,578 |
|
Operating Income/Expenses
|
-2,022,998 | -2,018,105 | -2,180,485 | -1,290,116 | -1,369,756 |
|
Total Operating Profit/Loss
|
423,114 | 467,986 | 111,429 | 1,390,740 | 1,570,411 |
| Total Net Finance Income/Expense
|
-97,872 | -142,173 | -116,203 | -104,249 | -113,186 |
| Net Investment Income
|
-39,088 | -57,309 | -98,742 | -956,011 | 101,396 |
| Irregular Income/Expenses
|
-198,213 | -199,533 | -404,116 | -1,044,457 | 2,875 |
|
Other Income/Expense, Non-Operating
|
-280,424 | 13,678 | 9,858 | -925,217 | -1,060,685 |
|
Non-Operating Income/Expenses, Total
|
-615,597 | -385,337 | -609,203 | -3,029,934 | -1,069,600 |
|
Pretax Income
|
-192,483 | 82,649 | -497,774 | -1,639,194 | 500,811 |
|
Provision for Income Tax
|
32,633 | -21,480 | -65,913 | -62,277 | -34,315 |
|
Net Income from Continuing Operations
|
-159,850 | 61,169 | -563,687 | -1,701,471 | 466,496 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-159,850 | 61,169 | -563,687 | -1,701,471 | 466,496 |
|
Non-Controlling/Minority Interests
|
123,918 | -29,749 | 309,738 | -132,218 | -156,126 |
|
Net Income after Non-Controlling/Minority Interests
|
-35,932 | 31,420 | -253,949 | -1,833,689 | 310,370 |
|
Net Income Available to Common Stockholders
|
-35,932 | 31,420 | -253,949 | -1,833,689 | 310,370 |
|
Dilution to Earnings
|
0 | -- | -- | 0 | -1,963 |
|
Diluted Net Income Available to Common Stockholders
|
-35,932 | 31,420 | -253,949 | -1,833,689 | 308,407 |
|
Common Dividend per Share
|
0.04 | 0.04 | 0.07 | 0.07 | 0.07 |
| Basic EPS
|
-0.02 | 0.02 | -0.17 | -1.23 | 0.21 |
| Diluted EPS
|
-0.02 | 0.02 | -0.17 | -1.23 | 0.20 |
|
Basic Weighted Average Shares Outstanding
|
1,480,951.975 | 1,479,653.394 | 1,476,659.150 | 1,487,154.911 | 1,506,786.693 |
|
Diluted Weighted Average Shares Outstanding
|
1,485,537.351 | 1,485,935.577 | 1,476,659.150 | 1,487,154.911 | 1,513,003.454 |
| Income Statement, Supplemental
|
12/31/2022 - 3/22/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade